Skip to main content

Table 10 Service use and costs (2011/12 £s) in four-week follow-up period between baseline (t1) and t3 for patients with non-malignant conditions

From: The clinical and cost effectiveness of a Breathlessness Intervention Service for patients with advanced non-malignant disease and their informal carers: mixed findings of a mixed method randomised controlled trial

 

Control arm (waiting list) (n = 38)

Intervention arm (fast-track) (n = 41)

Service

N (%) using service

Mean (SD) contacts-users only

Mean (SD) cost in £s -all sample

N (%) using service

Mean (SD) contacts-users only

Mean (SD) cost in £s -all sample

BIS intervention

2 (5)

1.5 (0.7)

4 (19)

3 (95)

2.1 (1.0)

156 (80)

Inpatienta

4 (11)

6.0 (3.4)

361 (1,200)

6 (15)

11.5 (8.3)

963 (2,895)

Other hospital services

19 (50)

2.5 (3.5)

145 (262)

20 (49)

1.7 (1.0)

108 (144)

GP

24 (63)

1.6 (0.7)

50 (63)

25 (61)

1.8 (1.2)

49 (57)

Nurse

16 (42)

2.5 (2.5)

28 (62)

21 (51)

2.7 (3.3)

41 (95)

Other health services

4 (11)

1.0 (0.0)

3 (11)

14 (34)

1.5 (1.1)

25 (59)

Social and other care

9 (24)

11.3 (22.8)

68 (269)

8 (20)

5.4 (4.6)

29 (75)

Total

659 (1253)

1,371 (2,948)

  1. aTwo of the six cases with inpatient stays in the fast-track group had stays substantially greater than for other admitted patients across both trial arms: these two admissions were unrelated to BIS